154 related articles for article (PubMed ID: 35568304)
1. Benefit of Extended Surveillance of Low-Risk Pancreatic Cysts After 5-Year Stability: A Systematic Review and Meta-Analysis.
Chhoda A; Singh S; Sheth AH; Grimshaw AA; Gunderson CG; Sharma P; Kunstman JW; Sharma A; Ahuja N; Gonda TA; Farrell JJ
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1430-1446. PubMed ID: 35568304
[TBL] [Abstract][Full Text] [Related]
2. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 Years of diagnosis.
Lee BS; Nguyen AK; Tekeste TF; Chang K; Girgis A; Adeyemo M; Hanna MS; Yao JF; Kwok KK; Giap AQ; Hunt GC; Chaya CT; Kao KT; Attam R; Ko A; Pio JR; Tovar S; Lim BS
Pancreatology; 2021 Jan; 21(1):144-154. PubMed ID: 33309223
[TBL] [Abstract][Full Text] [Related]
4. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
5. Long-term surveillance of branch-duct intraductal papillary mucinous neoplasms without worrisome or high-risk features.
Lattimore CM; Kane WJ; Subbarao S; Venitti C; Cramer CL; Turkheimer LM; Bauer TW; Turrentine FE; Zaydfudim VM
J Surg Oncol; 2023 Dec; 128(7):1087-1094. PubMed ID: 37530526
[TBL] [Abstract][Full Text] [Related]
6. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
Ohno E; Balduzzi A; Hijioka S; De Pastena M; Marchegiani G; Kato H; Takenaka M; Haba S; Salvia R
Pancreatology; 2024 Feb; 24(1):48-61. PubMed ID: 38161091
[TBL] [Abstract][Full Text] [Related]
7. Branch duct-intraductal papillary mucinous neoplasms (BD-IPMNs): an MRI-based radiomic model to determine the malignant degeneration potential.
Flammia F; Innocenti T; Galluzzo A; Danti G; Chiti G; Grazzini G; Bettarini S; Tortoli P; Busoni S; Dragoni G; Gottin M; Galli A; Miele V
Radiol Med; 2023 Apr; 128(4):383-392. PubMed ID: 36826452
[TBL] [Abstract][Full Text] [Related]
8. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management.
Crippa S; Pezzilli R; Bissolati M; Capurso G; Romano L; Brunori MP; Calculli L; Tamburrino D; Piccioli A; Ruffo G; Fave GD; Falconi M
Am J Gastroenterol; 2017 Jul; 112(7):1153-1161. PubMed ID: 28244498
[TBL] [Abstract][Full Text] [Related]
9. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Stopping Pancreatic Cyst Surveillance?
Farrell JJ
Am J Gastroenterol; 2017 Jul; 112(7):1162-1164. PubMed ID: 28725064
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.
Marchegiani G; Pollini T; Burelli A; Han Y; Jung HS; Kwon W; Rocha Castellanos DM; Crippa S; Belfiori G; Arcidiacono PG; Capurso G; Apadula L; Zaccari P; Noia JL; Gorris M; Busch O; Ponweera A; Mann K; Demir IE; Phillip V; Ahmad N; Hackert T; Heckler M; Lennon AM; Afghani E; Vallicella D; Dall'Olio T; Nepi A; Vollmer CM; Friess H; Ghaneh P; Besselink M; Falconi M; Bassi C; Goh BK; Jang JY; Fernández-Del Castillo C; Salvia R
Gastroenterology; 2023 Oct; 165(4):1016-1024.e5. PubMed ID: 37406887
[TBL] [Abstract][Full Text] [Related]
12. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features.
Kolb JM; Argiriadi P; Lee K; Liu X; Bagiella E; Gupta S; Lucas AL; Kim MK; Kumta NA; Nagula S; Sarpel U; DiMaio CJ
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1481-1487. PubMed ID: 29535058
[TBL] [Abstract][Full Text] [Related]
13. Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study.
Tamburrino D; de Pretis N; Pérez-Cuadrado-Robles E; Uribarri-Gonzalez L; Ateeb Z; Belfiori G; Maisonneuve P; Capurso G; Vanella G; Petrone MC; Arcidiacono PG; Vaalavuo Y; Frulloni L; Dominguez-Muñoz JE; Deprez PH; Falconi M; Del Chiaro M; Crippa S; Laukkarinen J
Br J Surg; 2022 Jun; 109(7):617-622. PubMed ID: 35511697
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for the Development of High-risk Stigmata in Branch-duct Intraductal Papillary Mucinous Neoplasms.
Yamazaki T; Tomoda T; Kato H; Miyamoto K; Matsumi A; Ueta E; Fujii Y; Saragai Y; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Okada H
Intern Med; 2021 Oct; 60(20):3205-3211. PubMed ID: 33967138
[TBL] [Abstract][Full Text] [Related]
15. Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis.
Choi SH; Park SH; Kim KW; Lee JY; Lee SS
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1509-1520.e4. PubMed ID: 28342950
[TBL] [Abstract][Full Text] [Related]
16. Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.
Crippa S; Piccioli A; Salandini MC; Cova C; Aleotti F; Falconi M
Updates Surg; 2016 Sep; 68(3):265-271. PubMed ID: 27502606
[TBL] [Abstract][Full Text] [Related]
17. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
18. Systematic review on surveillance for non-resected branch-duct intraductal papillary mucinous neoplasms of the pancreas.
Kazmi SZ; Jung HS; Han Y; Yun WG; Cho YJ; Lee M; Kwon W; Castillo CF; Del Chiaro M; Marchegiani G; Goh BKP; Hijioka S; Majumder S; Nakai Y; Shin A; Jang JY
Pancreatology; 2024 May; 24(3):463-488. PubMed ID: 38480047
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of intraductal papillary neoplasia of the pancreas (IPMN) under surveillance.
Johansson K; Kaprio T; Nieminen H; Lehtimäki TE; Lantto E; Haglund C; Seppänen H
Scand J Surg; 2022; 111(1):14574969221076792. PubMed ID: 35333109
[TBL] [Abstract][Full Text] [Related]
20. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
